Výsledky vyhľadávania

Nájdených záznamov: 3  
Váš dotaz: Autor-kód záznamu = "^sllk_un_auth p0058285^"
  1. SYSr007651
    LBL
      
    ^^^^^naa^^22^^^^^^^^450^
    005
      
    20130617120050.0
    100
      
    $a 20010502a2001 m y0sloc0103 ba
    101
    0-
    $a eng $d eng
    102
      
    $a SK
    200
    1-
    $a Cathepsin B and L and stefin A and B levels as serum tumor markers in squamous cell carcinoma of the head and neck $f P. Strojan ... [et al.]
    215
      
    $c Graf, tab.
    320
      
    $a Res. angl.
    320
      
    $a Bibliogr. odkazy
    463
    -1
    $1 001 sllk_un_cat*sg000148_2001_001_001 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Roč. 48, č. 1 (2001), s. 66-71
    541
    1-
    $a Hlainy katepsínu B a L a stefínu A a B ako sérové nádorové markery skvamózneho karcinómu hlavy a krku
    606
    0-
    $a katepsíny $x analýza $x použitie diagnostické $2 mesh $3 sllk_un_auth*d002403
    606
    0-
    $3 sllk_un_auth*d014408 $a biomarkery nádorové $x analýza $x použitie diagnostické $2 mesh
    606
    0-
    $a nádory zo skvamóznych buniek $x diagnostika $x patológia $2 mesh $3 sllk_un_auth*d018307
    606
    0-
    $a nádory hlavy a krku $x diagnostika $x patológia $2 mesh $3 sllk_un_auth*d006258
    675
      
    $a 611.91/.93:616-006 $v 1. stred. $z slo
    701
    -1
    $a Strojan $b P. $3 sllk_un_auth*p0058277 $4 070 $p Department of Radiotherapy, Institute of Oncology, S1-1000 Ljubljana, Slovenia
    702
    -1
    $a Budihna $b M. $3 sllk_un_auth*p0058278 $4 070 $p Department of Radiotherapy, Institute of Oncology, S1-1000 Ljubljana, Slovenia
    702
    -1
    $a Šmid $b L. $3 sllk_un_auth*p0058285 $4 070 $p University Department of otorhinolaryngology and Cervicofacial Surgery, SI-1000 Ljubljana, Slovenia
    702
    -1
    $a Svetic $b B. $3 sllk_un_auth*p0058459 $4 070 $p Department of Biochemistry, Institute of Oncology, SI-1000 Ljubljana, Slovenia
    702
    -1
    $a Vrhovec $b B. $3 sllk_un_auth*p0058622 $4 070 $p Department of Biochemistry, Institute of Oncology, SI-1000 Ljubljana, Slovenia
    702
    -1
    $a Škrk $b J. $3 sllk_un_auth*p0058623 $4 070 $p Department of Tumor Biology, Institute of Oncology, SI-1000 Ljubljana, Slovenia
    801
    -0
    $a SK $b BA006 $c 20010502 $g AACR2
  2. SYSr024918
    LBL
      
    ^^^^^naa^^22^^^^^^^^450^
    005
      
    20151102140044.5
    100
      
    $a 20040130a2003 m y0sloc0103 ba
    101
    0-
    $a eng $d eng
    102
      
    $a SK
    200
    1-
    $a Hemoglobin as factor influencing the outcome in inoperable oropharyngeal carcinoma treated by concomitant radiochemotherapy $f I. Oblak ... [et al.]
    320
      
    $a Res. angl.
    463
    -1
    $1 001 sllk_un_cat*sg000148_2003_003_006 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Vol. 50, no. 6 (2003), s. 452-458 $1 210 $a Bratislava $c Veda
    541
    1-
    $a Hemoglobín ako faktor, ktorý ovplyvňuje výsledky neoperabilného orofaryngeálneho karcinómu, liečeného konkomitantnou rádiochemoterapiou
    606
    1-
    $a nádory orofaryngu $2 mesh $3 sllk_un_auth*d009959 $9 .
    606
    1-
    $a hemoglobíny $x analýza $x použitie diagnostické $2 mesh $3 sllk_un_auth*d006454 $9 .
    606
    1-
    $a rádioterapia $2 mesh $3 sllk_un_auth*d011878 $9 .
    606
    2-
    $a farmakoterapia $x metódy $2 mesh $3 sllk_un_auth*d004358 $9 .
    606
    2-
    $a hemoglobíny $x analýza $x použitie diagnostické $2 mesh $3 sllk_un_auth*d006454 $9 .
    606
    2-
    $a prognóza $2 mesh $3 sllk_un_auth*d011379 $9 .
    606
    2-
    $a prežívanie $2 mesh $3 sllk_un_auth*d013534 $9 .
    675
      
    $a 616.32-006.6-085 $v 2. $z slo
    701
    -1
    $a Oblak $b I. $3 sllk_un_auth*p0033683 $4 070 $p Department of radiation oncology, University clinical centre, Ljubljana, Slovenia
    702
    -1
    $a Strojan $b P. $3 sllk_un_auth*p0058277 $4 070 $p Department of radiation oncology, University clinical centre, Ljubljana, Slovenia
    702
    -1
    $a Zakotnik $b B. $3 sllk_un_auth*p0033684 $4 070 $p Department of medical oncology, Institute of oncology, Ljubljana, Slovenia
    702
    -1
    $a Budihna $b M. $3 sllk_un_auth*p0058278 $4 070 $p Department of otorhinolaryngology and Cervicofacial surgery, University clinical centre, Ljubljana, Slovenia
    702
    -1
    $a Šmid $b L. $3 sllk_un_auth*p0058285 $4 070 $p Department of otorhinolaryngology and cervicofacial surgery, Clinical centre, Ljubjana, Slovenia
    801
    -0
    $a SK $b BA006 $c 20040130 $g AACR2
  3. SYSr032736
    LBL
      
    ^^^^^naa^^22^^^^^^^^450^
    005
      
    20130617161845.3
    100
      
    $a 20050418a2005 m y0sloc0103 ba
    101
    0-
    $a eng $d eng
    102
      
    $a SK
    200
    1-
    $a Inoperable oropharyngeal carcinoma treated with concomitant irradiation, mitomycin and bleomycin-long term results $f M. Budihna ... [et al.]
    215
      
    $c Grafy, tab.
    320
      
    $a Res. angl.
    320
      
    $a Bibliogr. odkazy
    463
    -1
    $1 001 sllk_un_cat*sg000148_2005_005_002 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Vol. 52, no. 2 (2005), p. 165-174 $1 210 $a Bratislava $c Veda
    541
    1-
    $a Inoperabilný orofaryngeálny karcinóm, liečený súčasne ožarovaním a podávaním mitomycínu C a bleomycínu - dlhodobé výsledky
    606
    1-
    $a nádory orofaryngu $x komplikácie $x diagnostika $x farmakoterapia $2 mesh $3 sllk_un_auth*d009959 $9 .
    606
    1-
    $a mitomycín $x aplikácia a dávkovanie $x použitie terapeutické $2 mesh $3 sllk_un_auth*d016685 $9 .
    606
    1-
    $a bleomycín $x aplikácia a dávkovanie $x použitie terapeutické $2 mesh $3 sllk_un_auth*d001761 $9 .
    606
    2-
    $a rádioterapia adjuvantná $x metódy $2 mesh $3 sllk_un_auth*d018714 $9 .
    606
    2-
    $a reakcia na dávku žiarenia $2 mesh $3 sllk_un_auth*d004307 $9 .
    606
    2-
    $a analýza prežívania $2 mesh $3 sllk_un_auth*d016019 $9 .
    606
    2-
    $a nádory hlavy a krku $x diagnostika $x farmakoterapia $2 mesh $3 sllk_un_auth*d006258 $9 .
    675
      
    $a 611.91/.93-006.6-085 $v 2. $z slo
    701
    -1
    $a Budihna $b M. $3 sllk_un_auth*p0058278 $4 070 $p Institute of oncology, Ljubljana, Slovenia
    701
    -1
    $a Šoba $b E. $3 sllk_un_auth*p0040695 $4 070 $p Institute of oncology, Ljubljana, Slovenia
    701
    -1
    $a Šmid $b L. $3 sllk_un_auth*p0058285 $4 070 $p University department of otorhinolaryngeal and cervicofacial surgery, Ljubljana, Slovenia
    701
    -1
    $a Zakotnik $b B. $3 sllk_un_auth*p0033684 $4 070 $p Institute of oncology, Ljubljana, Slovenia
    701
    -1
    $a Strojan $b P. $3 sllk_un_auth*p0058277 $4 070 $p Institute of oncology, Ljubljana, Slovenia
    701
    -1
    $a Čemažar $b P. $3 sllk_un_auth*p0040696 $4 070 $p Institute of oncology, Ljubljana, Slovenia
    701
    -1
    $a Fajdiga $b I. $3 sllk_un_auth*p0040697 $4 070 $p University department of otorhinolaryngology and cervicofacial surgery, Ljubljana, Slovenia
    701
    -1
    $a Žargi $b M. $3 sllk_un_auth*p0040698 $4 070 $p University department of otorhinolaryngology and cervicofacial surgery, Ljubljana, Slovenia
    701
    -1
    $a Župevc $b A. $3 sllk_un_auth*p0040702 $4 070 $p University department of otorhinolaryngology and cervicofacial surgery, Ljubljana, Slovenia
    701
    -1
    $a Lešničar $b H. $3 sllk_un_auth*p0040701 $4 070 $p Institute of oncology, Ljubljana, Slovenia
    801
    -0
    $a SK $b BA006 $c 20050418 $g AACR2


  Tieto stránky využívajú súbory cookies, ktoré uľahčujú ich prezeranie. Ďalšie informácie o tom ako používame cookies.